NO895193L - Fremgangsmaate for fremstilling av kinoxalinforbindelser. - Google Patents

Fremgangsmaate for fremstilling av kinoxalinforbindelser.

Info

Publication number
NO895193L
NO895193L NO89895193A NO895193A NO895193L NO 895193 L NO895193 L NO 895193L NO 89895193 A NO89895193 A NO 89895193A NO 895193 A NO895193 A NO 895193A NO 895193 L NO895193 L NO 895193L
Authority
NO
Norway
Prior art keywords
compounds
kinoxal
procedure
preparation
hydrogen
Prior art date
Application number
NO89895193A
Other languages
English (en)
Other versions
NO178661B (no
NO178661C (no
NO895193D0 (no
Inventor
Tage Honore
Poul Jacobsen
Flemming Elmelund Nielsen
Lars Naerum
Original Assignee
Ferrosan As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferrosan As filed Critical Ferrosan As
Publication of NO895193D0 publication Critical patent/NO895193D0/no
Publication of NO895193L publication Critical patent/NO895193L/no
Publication of NO178661B publication Critical patent/NO178661B/no
Publication of NO178661C publication Critical patent/NO178661C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/50—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to ring nitrogen atoms
    • C07D241/52—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Luminescent Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Television Signal Processing For Recording (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO895193A 1988-12-22 1989-12-21 Analogifremgangsmåte for fremstilling av terapeutisk virksomme kinoksalinforbindelser NO178661C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK715888A DK715888D0 (da) 1988-12-22 1988-12-22 Quinoxalinforbindelser, deres fremstilling og anvendelse

Publications (4)

Publication Number Publication Date
NO895193D0 NO895193D0 (no) 1989-12-21
NO895193L true NO895193L (no) 1990-06-25
NO178661B NO178661B (no) 1996-01-29
NO178661C NO178661C (no) 1996-05-08

Family

ID=8149230

Family Applications (1)

Application Number Title Priority Date Filing Date
NO895193A NO178661C (no) 1988-12-22 1989-12-21 Analogifremgangsmåte for fremstilling av terapeutisk virksomme kinoksalinforbindelser

Country Status (16)

Country Link
US (1) US5061706A (no)
EP (1) EP0377112B1 (no)
JP (1) JPH02221263A (no)
AT (1) ATE110371T1 (no)
AU (1) AU626093B2 (no)
CA (1) CA2004078A1 (no)
DE (1) DE68917708T2 (no)
DK (1) DK715888D0 (no)
ES (1) ES2058450T3 (no)
FI (1) FI896235A7 (no)
IE (1) IE66561B1 (no)
IL (1) IL92463A (no)
NO (1) NO178661C (no)
NZ (1) NZ231906A (no)
PT (1) PT92714B (no)
ZA (1) ZA899469B (no)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK69790D0 (da) * 1990-03-16 1990-03-16 Novo Nordisk As Heterocykliske forbindelser, deres fremstilling af anvendelse
HU221425B (en) * 1990-11-06 2002-10-28 Yamanouchi Pharma Co Ltd Condensed pyrazine derivatives, process for their production and pharmaceutical preparations containing these compounds
PT99864B (pt) 1990-12-21 1999-06-30 Schering Ag Processo para a preparacao de novas composicoes farmaceuticas contendo antagonistas de receptor de quisqualato
DE4217952A1 (de) * 1992-05-30 1993-12-02 Basf Ag Chinoxalin-2,3(1H,4H)-dione
EP0647137B1 (en) * 1992-06-22 2008-08-13 The Regents Of The University Of California Glycine receptor antagonists and the use thereof
US5631373A (en) * 1993-11-05 1997-05-20 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon, Eugene Oregon Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones
DE4340045A1 (de) * 1993-11-24 1995-06-01 Basf Ag Neue Chinoxaline und Arzneimittel daraus
AU688459B2 (en) * 1994-04-08 1998-03-12 Shionogi & Co., Ltd. Oxopyridinylquinoxaline derivative
DE4428152A1 (de) * 1994-06-22 1996-01-04 Basf Ag Neue Amido-chinoxalindione, ihrer Herstellung und Verwendung
EP0705834A1 (de) * 1994-07-27 1996-04-10 Ciba-Geigy Ag Azaaliphatisch Überbrückte Chinoxalin-2,3-dione
EP0705835A1 (de) * 1994-09-01 1996-04-10 Ciba-Geigy Ag Oxa- oder thiaaliphatisch überbrückte Chinoxalin-2,3-dione
GB9418443D0 (en) * 1994-09-13 1994-11-02 Pfizer Ltd Therapeutic agents
GB9419318D0 (en) * 1994-09-24 1994-11-09 Pfizer Ltd Therapeutic agents
DE4436852A1 (de) * 1994-10-14 1996-04-18 Basf Ag Pyrrolyl-tetrahydrobenzochinoxalindione, ihre Herstellung und Verwendung
DE19521058A1 (de) * 1995-06-09 1996-12-12 Basf Ag Verfahren zur Herstellung von Aromaten enthaltenden Polyetherpolyolen
DE19624808A1 (de) 1996-06-21 1998-01-02 Basf Ag Pyrrolylchinoxalindione, ihre Herstellung und Verwendung
WO1997049684A1 (en) * 1996-06-24 1997-12-31 Novo Nordisk A/S Factor vii-binding reagent
HUP0001311A3 (en) * 1997-02-18 2001-07-30 American Home Products Corp Ma 5-aminoalkoxy-1,4-dihydroquinoxaline-2,3-diones being dopamine agonists and pharmaceutical compositions containing them
US5922715A (en) * 1997-02-18 1999-07-13 American Home Products Corporation 5-aminoalkoxy-1, 4-dihydroquinoxaline-2, 3-diones
EP2338492A1 (en) 2009-12-24 2011-06-29 Universidad del Pais Vasco Methods and compositions for the treatment of alzheimer
EP3427729A1 (en) 2017-07-13 2019-01-16 Paris Sciences et Lettres - Quartier Latin Probenecid for use in treating epileptic diseases, disorders or conditions

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3992378A (en) * 1973-12-26 1976-11-16 Eli Lilly And Company Fluoralkyl quinoxadinediones
US4812458A (en) * 1986-09-16 1989-03-14 A/S Ferrosan 6,7-disubstituted-2,3-dihydroxyquinoxaline compounds, pharmaceutical compositions thereof, and their use as neuroleptics
DK146787A (da) * 1987-03-23 1988-09-24 Ferrosan Heterocykliske forbindelser, deres fremstilling og anvendelse
NO179551C (no) * 1987-11-10 1996-10-30 Novo Nordisk As Analogifremgangsmåte for fremstilling av terapeutisk virksomme kinoxalinforbindelser

Also Published As

Publication number Publication date
AU626093B2 (en) 1992-07-23
NO178661B (no) 1996-01-29
PT92714A (pt) 1990-06-29
IL92463A0 (en) 1990-08-31
CA2004078A1 (en) 1990-06-22
EP0377112A1 (en) 1990-07-11
JPH02221263A (ja) 1990-09-04
US5061706A (en) 1991-10-29
DK715888D0 (da) 1988-12-22
IE893749L (en) 1990-06-22
ES2058450T3 (es) 1994-11-01
NO178661C (no) 1996-05-08
PT92714B (pt) 1996-01-31
IE66561B1 (en) 1996-01-24
ZA899469B (en) 1990-09-26
FI896235A7 (fi) 1990-06-23
FI896235A0 (fi) 1989-12-22
NO895193D0 (no) 1989-12-21
IL92463A (en) 1995-03-15
ATE110371T1 (de) 1994-09-15
DE68917708D1 (de) 1994-09-29
EP0377112B1 (en) 1994-08-24
NZ231906A (en) 1991-11-26
AU4687289A (en) 1990-06-28
DE68917708T2 (de) 1994-12-15

Similar Documents

Publication Publication Date Title
NO895196D0 (no) Fremgangsmaate for fremstilling av kinoxalinforbindelser.
NO895193L (no) Fremgangsmaate for fremstilling av kinoxalinforbindelser.
NO884729L (no) Fremgangsmaate for fremstilling av kinoxalinforbindelser.
NO874350D0 (no) Fremgangsmaate for fremstilling av antibakterielle forbindelser.
NO881264L (no) Fremgangsmaate for fremstilling av heterocykliske forbindelser.
NO873873L (no) Kinoxalinforbindelser samt fremgangsmaate for fremstilling derav.
ATE71078T1 (de) Glyzerinderivate.
DE69018726D1 (de) Cumarinderivate, ihre Herstellung und ihre Verwendung zur Behandlung von zerebrovaskulären Störungen.
DK639889A (da) Quinoxalinforbindelser, deres fremstilling og anvendelse
DK639789A (da) Quinoxalinforbindelser, deres fremstilling og anvendelse